Log In
Print
BCIQ
Print
Print this Print this
 

VLST-007

  Manage Alerts
Collapse Summary General Information
Company VLST Corp.
DescriptionDimeric protein comprised of human CD47 extracellular domain fused to the Fc portion of a human IgG1 molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat inflammation in autoimmune diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today